PEGylated liposomal doxorubicin targeted to α 5β 1-expressing MDA-MB-231 breast cancer cells

Langmuir

Volumn 28, Issue 10, 2012, Pages 4729-4736

  Shroff, Kamlesh ^a   Kokkoli, Efrosini ^a  

^a University of Minnesota   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE TARGETING; BI-LAYER; BREAST CANCER CELLS; CANCER CELLS; CANCER PATIENTS; CANCER THERAPY; CYTOTOXIC; DELIVERY SYSTEMS; DOXORUBICIN; ENDOSOMES; FUNCTIONALIZED; IN-VITRO; IN-VIVO; INTEGRINS; INTRACELLULAR TRAFFICKING; LATE ENDOSOMES; LIPOSOMAL DOXORUBICIN; NON-TARGETED; PEGYLATED LIPOSOMES; PEGYLATED NANOPARTICLE; PEGYLATION; SIDE EFFECT; SPECIFIC SITES; STEALTH LIPOSOMES; THERAPEUTIC POTENTIALS; TUMOR VASCULATURE;

BIOMIMETICS; CELLS; CYTOTOXICITY; DRUG DELIVERY; DRUG INTERACTIONS; LIPOSOMES; PEPTIDES; POLYETHYLENE GLYCOLS;

PHOSPHOLIPIDS;

ANTINEOPLASTIC AGENT; BIOMIMETIC MATERIAL; DOXORUBICIN; DRUG DERIVATIVE; LIGAND; LIPOSOME; MACROGOL DERIVATIVE; NANOCONJUGATE; OLIGOPEPTIDE; SURFACTANT; VERY LATE ACTIVATION ANTIGEN 5;

ARTICLE; BREAST TUMOR; CELL SURVIVAL; DRUG DELIVERY SYSTEM; DRUG EFFECT; FEMALE; HUMAN; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BIOMIMETIC MATERIALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; INTEGRIN ALPHA5BETA1; LIGANDS; LIPOSOMES; NANOCONJUGATES; OLIGOPEPTIDES; POLYETHYLENE GLYCOLS; SURFACE-ACTIVE AGENTS;

EID: 84858241851     PISSN: 07437463     EISSN: 15205827     Source Type: Journal    
DOI: 10.1021/la204466g     Document Type: Article

References (72)

1. Peer, D.; Karp, J. M.; Hong, S.; FaroKhzad, O. C.; Margalit, R.; Langer, R. Nat. Nanotechnol. 2007, 2, 751
2. Thierry, B. Curr. Drug Delivery 2009, 6, 391
3. Torchilin, V. P. AAPS J. 2007, 9, E128
4. Owens, D. E.; Peppas, N. A. Int. J. Pharm. 2006, 307, 93
5. Allen, T. M.; Hansen, C. Biochim. Biophys. Acta 1991, 1068, 133
6. Allen, T. M. Trends Pharmacol. Sci. 1994, 15, 215
7. Yuan, F.; Leunig, M.; Huang, S. K.; Berk, D. A.; Papahadjopoulos, D.; Jain, R. K. Cancer Res. 1994, 54, 3352
8. Moghimi, S. M.; Szebeni, J. Prog. Lipid Res. 2003, 42, 463
9. Meenach, S. A.; Hilt, J. Z.; Anderson, K. W. Acta Biomater. 2010, 6, 1039
10. Working, P. K.; Newman, M. S.; Sullivan, T.; Yarrington, J. J. Pharmacol. Exp. Ther. 1999, 289, 1128
11. Gabizon, A.; Martin, F. Drugs 1997, 54, 15
12. Safra, T.; Muggia, F.; Jeffers, S.; Tsao-Wei, D. D.; Groshen, S.; Lyass, O.; Henderson, R.; Berry, G.; Gabizon, A. Ann. Oncol. 2000, 11, 1029
13. Lyass, O.; Uziely, B.; Ben-Yosef, R.; Tzemach, D.; Heshing, N. I.; Lotem, M.; Brufman, G.; Gabizon, A. Cancer 2000, 89, 1037
14. Gabizon, A. A. Cancer Invest. 2001, 19, 424
15. Howlader, N; Noone, A. M.; Krapcho, M; Neyman, N; Aminou, R; Waldron, W; Altekruse, S. F.; Kosary, C. L.; Ruhl, J; Tatalovich, Z; Cho, H; Mariotto, A; Eisner, M. P.; Lewis, D. R.; Chen, H. S.; Feuer, E. J.; Cronin, K. A., Eds; http://seer.cancer.gov/csr/1975-2008/; based on November 2010 SEER data submission, posted to the SEER website, 2011.
16. Perez, A. T.; Domenech, G. H.; Frankel, C.; Vogel, C. L. Cancer Invest. 2002, 20, 22
17. Gabizon, A.; Shmeeda, H.; Barenholz, Y. Clin. Pharmacokinet. 2003, 42, 419
18. Tu, R. S.; Tirrell, M. Adv. Drug Delivery Rev. 2004, 56, 1537
19. Biesalski, M.; Tu, R.; Tirrell, M. V. Langmuir 2005, 21, 5663
20. Marques, B. F.; Schneider, J. W. Langmuir 2005, 21, 2488
21. Marques, B. F.; Schneider, J. W. Colloids Surf., B: Biointerfaces 2006, 53, 1
22. Torchilin, V. P. Nat. Rev. Drug Discovery 2005, 4, 145
23. Mastrobattista, E.; Koning, G. A.; Storm, G. Adv. Drug Delivery Rev. 1999, 40, 103
24. Park, J. W.; Benz, C. C.; Martin, F. J. Semin. Oncol. 2004, 31, 196
25. Parsons-Wingerter, P.; Kasman, I. M.; Norberg, S.; Magnussen, A.; Zanivan, S.; Rissone, A.; Baluk, P.; Favre, C. J.; Jeffry, U.; Murray, R.; McDonald, D. M. Am. J. Pathol. 2005, 167, 193
26. Jin, H.; Varner, J. Br. J. Cancer 2004, 90, 561
27. Jayne, D. G.; Heath, R. M.; Dewhurst, O.; Scott, N.; Guillou, P. J. Eur. J. Surg. Oncol. 2002, 28, 30
28. Serini, G.; Valdembri, D.; Bussolino, F. Exp. Cell Res. 2006, 312, 651
29. Serini, G.; Napione, L.; Arese, M.; Bussolino, F. Cardiovasc. Res. 2008, 78, 213
30. Honn, K. V.; Tang, D. G. Cancer Metastasis Rev. 1992, 11, 353
31. Ellis, L. M. Am. Surg. 2003, 69, 3
32. Stoeltzing, O.; Liu, W. B.; Reinmuth, N.; Fan, F.; Parry, G. C.; Parikh, A. A.; McCarty, M. F.; Bucana, C. D.; Mazar, A. P.; Ellis, L. M. Int. J. Cancer 2003, 104, 496
33. Livant, D. L. Curr. Cancer Drug Targets 2005, 5, 489
34. Alghisi, G. C.; Ruegg, C. Endothelium-J. Endothelial Cell Res. 2006, 13, 113
35. Hart, S. L.; Knight, A. M.; Harbottle, R. P.; Mistry, A.; Hunger, H. D.; Cutler, D. F.; Williamson, R.; Coutelle, C. J. Biol. Chem. 1994, 269, 12468
36. Xiong, X. B.; Huang, Y.; Lu, W. L.; Zhang, H.; Zhang, X.; Zhang, Q. Pharm. Res. 2005, 22, 933
37. Xiong, X. B.; Huang, Y.; Lu, W. L.; Zhang, X.; Zhang, H.; Nagai, T.; Zhang, Q. J. Controlled Release 2005, 107, 262
38. Xiong, X. B.; Huang, Y.; Lu, W. L.; Zhang, X.; Zhang, H.; Nagai, T.; Zhang, Q. J. Pharm. Sci. 2005, 94, 1782
39. Pangburn, T. O.; Petersen, M. A.; Waybrant, B.; Adil, M. M.; Kokkoli, E. J. Biomech. Eng. 2009, 131, 74005
40. Kokkoli, E.; Mardilovich, A.; Wedekind, A.; Rexeisen, E. L.; Garg, A.; Craig, J. A. Soft Matter 2006, 2, 1015
41. Schiffelers, R. M.; Koning, G. A.; ten Hagen, T. L. M.; Fens, M.; Schraa, A. J.; Janssen, A.; Kok, R. J.; Molema, G.; Storm, G. J. Controlled Release 2003, 91, 115
42. Mardilovich, A.; Kokkoli, E. Biomacromolecules 2004, 5, 950
43. Mardilovich, A.; Kokkoli, E. Langmuir 2005, 21, 7468
44. Mardilovich, A.; Craig, J. A.; McCammon, M. Q.; Garg, A.; Kokkoli, E. Langmuir 2006, 22, 3259
45. Craig, J. A.; Rexeisen, E. L.; Mardilovich, A.; Shroff, K.; Kokkoli, E. Langmuir 2008, 24, 10282
46. Rexeisen, E. L.; Fan, W.; Pangburn, T. O.; Taribagil, R. R.; Bates, F. S.; Lodge, T. P.; Tsapatsis, M.; Kokkoli, E. Langmuir 2010, 26, 1953
47. Shroff, K.; Rexeisen, E. L.; Arunagirinathan, M. A.; Kokkoli, E. Soft Matter 2010, 6, 5064
48. Shroff, K.; Pearce, T. R.; Kokkoli, E. Langmuir 2012, 28, 1858
49. Pangburn, T. O.; Bates, F. S.; Kokkoli, E. Soft Matter 2012, in press (DOI: 10.1039/C2SM06922A)
50. Garg, A.; Tisdale, A. W.; Haidari, E.; Kokkoli, E. Int. J. Pharm. 2009, 366, 201
51. Garg, A.; Kokkoli, E. Curr. Pharm. Biotechnol. 2011, 12, 1135
52. Demirgoz, D.; Garg, A.; Kokkoli, E. Langmuir 2008, 24, 13518
53. Demirgoz, D.; Pangburn, T. O.; Davis, K. P.; Lee, S.; Bates, F. S.; Kokkoli, E. Soft Matter 2009, 5, 2011
54. Atchison, N. A.; Fan, W.; Papas, K. K.; Hering, B. J.; Tsapatsis, M.; Kokkoli, E. Langmuir 2010, 26, 14081
55. Berndt, P.; Fields, G. B.; Tirrell, M. J. Am. Chem. Soc. 1995, 117, 9515
56. Haran, G.; Cohen, R.; Bar, L. K.; Barenholz, Y. Biochim. Biophys. Acta 1993, 1151, 201
57. Vichai, V.; Kirtikara, K. Nat. Protocols 2006, 1, 1112
58. Gui, G. P. H; Puddefoot, J. R.; Vinson, G. P.; Wells, C. A.; Carpenter, R. Br. J. Surg. 1995, 82, 1192
59. van der Pluijm, G.; Vloedgraven, H.; Papapoulos, S.; Lowik, C.; Grzesik, W.; Kerr, J.; Robey, P. G. Lab. Invest. 1997, 77, 665
60. Newton, S. A.; Reeves, E. J.; Gralnick, H.; Mohla, S.; Yamada, K. M.; Olden, K.; Akiyama, S. K. Int. J. Oncol. 1995, 6, 1063
61. Maitani, Y. J. Drug Delivery Sci. Technol. 2011, 21, 27
62. Thanou, M.; Wang, M. Pharmacol. Res. 2010, 62, 90
63. Howard, M. D.; Jay, M.; Dziublal, T. D.; Lu, X. J. Biomed. Nanotechnol. 2008, 4, 133
64. Gabizon, A. A.; Shmeeda, H.; Zalipsky, S. J. Liposome Res. 2006, 16, 175
65. Immordino, M. L.; Dosio, F.; Cattel, L. Int. J. Nanomed. 2006, 1, 297
66. Huynh, N. T.; Roger, E.; Lautram, N.; Benoit, J. P.; Passirani, C. Nanomedicine 2010, 5, 1415
67. Harasym, T. O.; Bally, M. B.; Tardi, P. Adv. Drug Delivery Rev. 1998, 32, 99
68. Gabizon, A.; Horowitz, A. T.; Goren, D.; Tzemach, D.; Shmeeda, H.; Zalipsky, S. Clin. Cancer Res. 2003, 9, 6551
69. Cho, K. J.; Wang, X.; Nie, S. M.; Chen, Z.; Shin, D. M. Clin. Cancer Res. 2008, 14, 1310
70. Colin, M.; Maurice, M.; Trugnan, G.; Kornprobst, M.; Harbottle, R. P.; Knight, A.; Cooper, R. G.; Miller, A. D.; Capeau, J.; Coutelle, C.; Brahimi-Horn, M. C. Gene Ther. 2000, 7, 139
71. Garde, S. V.; Forte, A. J.; Ge, M.; Lepekhin, E. A.; Panchal, C. J.; Rabbani, S. A.; Wu, J. J. Anti-Cancer Drugs 2007, 18, 1189
72. Obata, Y.; Tajima, S.; Takeoka, S. J. Controlled Release 2010, 142, 267